Pharmaceuticals, Biotechnology and Life Sciences
– Data from an open-label Phase 2 study of the treatment of upper facial lines with DaxibotulinumtoxinA for Injection highlighted…
– Encouraging preclinical data presented in 2020 support advancement to clinical evaluation for XL102, Exelixis’ novel oral CDK7 inhibitor –…
SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced the release of MassHunter Workstation Plus 11.0, MassHunter Networked Workstation…
– Encouraging preclinical data presented in 2020 support advancement to clinical evaluation for XL102, Exelixis’ novel oral CDK7 inhibitor –…
DUBLIN–(BUSINESS WIRE)–The “Global Renal Fibrosis Clinical Trial Pipeline Highlights – 2021” report has been added to ResearchAndMarkets.com’s offering. Renal Fibrosis…
DUBLIN–(BUSINESS WIRE)–The “Global Renal Fibrosis Clinical Trial Pipeline Highlights – 2021” report has been added to ResearchAndMarkets.com’s offering. Renal Fibrosis…
DUBLIN–(BUSINESS WIRE)–The “Global Renal Fibrosis Clinical Trial Pipeline Highlights – 2021” report has been added to ResearchAndMarkets.com’s offering. Renal Fibrosis…
DUBLIN–(BUSINESS WIRE)–The “Global Primary Biliary Cirrhosis Clinical Trial Pipeline Highlights – 2021” report has been added to ResearchAndMarkets.com’s offering. Primary…
DUBLIN–(BUSINESS WIRE)–The “Global Primary Biliary Cirrhosis Clinical Trial Pipeline Highlights – 2021” report has been added to ResearchAndMarkets.com’s offering. Primary…
HEMEL HEMPSTEAD, England & BEIJING, China & CAMBRIDGE, Mass.–(BUSINESS WIRE)–EUSA Pharma (UK) Limited and BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160)…